Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Two racehorses test positive for banned substance
Under World Anti-Doping Agency Rules, EPO has been banned for use by human athletes since the 1990s. (stock photo)
FEI reveals positive drugs tests conducted in Doha
 
Two horses and their riders have tested positive for the banned substance human Erythropoietin (EPO).  

Samples taken on 22 April from a race in Doha contained the substance banned under the FEI’s Equine Anti Doping and Controlled Medication Regulations.

The winning horse Centurion, and second placed horse SUR, returned positive samples of EPO, a performance-enhancing drug, banned for equine use since 2010.

FEI veterinary director Göran Akerström said: “EPO is well known in human endurance sports in which an increased number of oxygen-carrying red blood cells is an advantage, but the substance has little benefit in equestrian sport and this is the first time we have seen FEI horses testing positive for EPO”.

Under World Anti-Doping Agency Rules, EPO has been banned for use by human athletes since the 1990s. It is a peptide hormone that is released from the kidneys to stimulate bone marrow to produce red blood cells. This improves blood oxygenation in the muscles.  

However, Akerström continued: “The use of EPO would have a negative effect in many horses as the increased level of red blood cells would slow down blood circulation.”

FEI secretary general Sabrina Ibanez said: “We will take whatever measures are necessary to ensure that there is no room in our sport for those who attempt to gain a competitive advantage through the use of prohibited substances”.

The horses and jockeys have commenced provisional two-month suspensions effective from the date of notification, 2 June, 2016.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.